Isaias Dichi

Prof. Dr. Isaias Dichi

Department of Internal Medicine-University of Londrina, Londrina, Paraná, Brazil

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2014 in Nutrition
Verified
Journal Article
Closed access
FBFabíola Málaga Barreto
Fabíola Málaga Barreto
ASAndréa Name Colado Simão
Andréa Name Colado Simão
HMHelena Kaminami Morimoto
Helena Kaminami Morimoto
MLMarcell Alysson Batisti Lozovoy
Marcell Alysson Batisti Lozovoy
Isaias DichiIsaias Dichi
Isaias Dichi
LMLúcia Helena da Silva Miglioranza
Lúcia Helena da Silva Miglioranza

1 June 2015 in Nutrition
Verified
Journal Article
Closed access
DVDanielle Venturini
Danielle Venturini
ASAndréa Name Colado Simão
Andréa Name Colado Simão
MUMariana Ragassi Urbano
Mariana Ragassi Urbano
Isaias DichiIsaias Dichi
Isaias Dichi

1 February 2000 in Nutrition
Verified
Journal Article
Closed access
Isaias DichiIsaias Dichi
Isaias Dichi
PFPatrícia Frenhane
Patrícia Frenhane
JDJane B Dichi
Jane B Dichi
CCCamila R Correa
Camila R Correa
AAAparecida Y.O Angeleli
Aparecida Y.O Angeleli
RBRoberto C Burini
Roberto C Burini

1 April 2019 in Nutrition
Verified
Journal Article
Closed access
NTNataly Simões Bandiera Thimóteo
Nataly Simões Bandiera Thimóteo
TITatiana Mayumi Veiga Iryioda
Tatiana Mayumi Veiga Iryioda
DADaniela Frizon Alfieri
Daniela Frizon Alfieri
BRBrunna Emanuella França Rego
Brunna Emanuella França Rego
BSBruna Miglioranza Scavuzzi
Bruna Miglioranza Scavuzzi
Isaias DichiIsaias Dichi
Isaias Dichi

28 September 2012 in Expert Opinion on Therapeutic Targets
Verified
Journal Article
Closed access
ASAndréa Name Colado Simão
Andréa Name Colado Simão
MLMarcell Alysson Batisti Lozovoy
Marcell Alysson Batisti Lozovoy
Isaias DichiIsaias Dichi
Isaias Dichi
Introduction: Uric acid (UA) increase is considered an important risk factor for the development of cardiovascular disease (CVD) favoring oxidative stress and endothelial dysfunction and is also involved in metabolic syndrome (MS) pathophysiology. Areas covered: Insulin has a physiological action on renal tubules, causing a reduction in UA clearance, what could explain the hyperuricemia found in MS. On the other hand, it was also hypothesized a causal role of UA in fructose-induced MS. Moreover, it has been suggested that higher UA levels predict the development of MS. MS subjects present a redox imbalance and UA participates in this process. UA can contribute to oxidative stress present in MS; however, it has also an important role in the antioxidant defense system. Although UA may have a protective effect due to its antioxidant properties, it is clear that the dominant effect of UA in MS is deleterious. All-cause mortality and CVD have been shown to be increased with higher UA levels. Expert opinion: It is extremely important to prescribe drugs which concomitantly decrease hyperuricemia and improve co-morbidities associated with hyperuricemia. Long-term studies to verify the consequences of decreasing UA concentration below current recommendations in asymptomatic patients are needed.

10 June 2009 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
DVDanielle Venturini
Danielle Venturini
ASAndréa Name Colado Simão
Andréa Name Colado Simão
DBDécio Sabbatini Barbosa
Décio Sabbatini Barbosa
ELEdson Lopes Lavado
Edson Lopes Lavado
VNVictor Emanuel Soares Narciso
Victor Emanuel Soares Narciso
JDJane Bandeira Dichi
Jane Bandeira Dichi